AMBONI, Marianna
 Distribuzione geografica
Continente #
AS - Asia 11.962
NA - Nord America 5.770
EU - Europa 2.280
SA - Sud America 832
OC - Oceania 56
AF - Africa 54
Continente sconosciuto - Info sul continente non disponibili 5
Totale 20.959
Nazione #
HK - Hong Kong 9.005
US - Stati Uniti d'America 5.651
SG - Singapore 1.355
CN - Cina 705
BR - Brasile 682
IT - Italia 409
RU - Federazione Russa 399
VN - Vietnam 361
UA - Ucraina 345
DE - Germania 298
IE - Irlanda 217
TR - Turchia 185
SE - Svezia 155
KR - Corea 145
GB - Regno Unito 115
EE - Estonia 107
FI - Finlandia 73
CA - Canada 66
AR - Argentina 63
IN - India 46
BD - Bangladesh 32
EC - Ecuador 32
FR - Francia 32
AU - Australia 30
JP - Giappone 29
PL - Polonia 28
MX - Messico 27
NZ - Nuova Zelanda 24
ID - Indonesia 23
NL - Olanda 17
ZA - Sudafrica 17
CZ - Repubblica Ceca 16
ES - Italia 15
IQ - Iraq 15
PY - Paraguay 13
VE - Venezuela 12
PK - Pakistan 11
AT - Austria 10
CO - Colombia 10
IL - Israele 8
MA - Marocco 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
BE - Belgio 7
CL - Cile 7
KE - Kenya 7
PE - Perù 7
LT - Lituania 6
NP - Nepal 6
AL - Albania 5
EU - Europa 5
JM - Giamaica 5
DO - Repubblica Dominicana 4
EG - Egitto 4
ET - Etiopia 4
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
CH - Svizzera 3
DZ - Algeria 3
GT - Guatemala 3
HR - Croazia 3
ME - Montenegro 3
OM - Oman 3
TN - Tunisia 3
UY - Uruguay 3
BH - Bahrain 2
BO - Bolivia 2
BS - Bahamas 2
BW - Botswana 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
IR - Iran 2
JO - Giordania 2
NI - Nicaragua 2
PA - Panama 2
PR - Porto Rico 2
RS - Serbia 2
SA - Arabia Saudita 2
TH - Thailandia 2
TJ - Tagikistan 2
CY - Cipro 1
DM - Dominica 1
GA - Gabon 1
GF - Guiana Francese 1
GP - Guadalupe 1
HN - Honduras 1
KY - Cayman, isole 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
MR - Mauritania 1
NC - Nuova Caledonia 1
RO - Romania 1
RW - Ruanda 1
SI - Slovenia 1
Totale 20.956
Città #
Hong Kong 8.993
Ann Arbor 1.105
Singapore 594
Princeton 518
Chandler 509
Wilmington 468
Jacksonville 429
Dallas 403
Ashburn 278
Houston 255
Dublin 204
Woodbridge 201
Izmir 166
Beijing 159
Dong Ket 136
Nanjing 112
Moscow 110
Tallinn 107
Andover 104
Boardman 86
Ho Chi Minh City 74
Salerno 69
Munich 65
Pellezzano 64
São Paulo 60
Los Angeles 57
Düsseldorf 55
Norwalk 53
Hanoi 52
Dearborn 44
Shenyang 43
Nanchang 39
Naples 36
Fairfield 34
Mestre 34
New York 32
Hebei 29
Redwood City 26
Rio de Janeiro 26
Jiaxing 25
San Francisco 25
Changsha 21
Rome 21
Warsaw 21
Montreal 20
The Dalles 20
Pune 18
Santa Clara 18
Tianjin 18
Council Bluffs 17
Brooklyn 16
Milan 16
Nuremberg 16
San Diego 16
Washington 16
Boston 15
Haiphong 15
Atlanta 14
Casoria 14
Chennai 14
Guarulhos 14
Tokyo 14
Belo Horizonte 13
Poplar 13
Stockholm 13
Turku 13
Ankara 12
Brasília 12
London 12
Porto Alegre 12
Seoul 12
Amsterdam 11
Auckland 11
Guangzhou 11
Phoenix 11
Quito 11
Sydney 11
Columbus 10
Curitiba 10
Denver 10
West Jordan 10
Campinas 9
Dhaka 9
Frankfurt am Main 9
Guayaquil 9
Cape Town 8
Ribeirão Preto 8
Salvador 8
Seattle 8
Wuhan 8
Cambridge 7
Carapicuíba 7
Chicago 7
Jinan 7
Manchester 7
Nairobi 7
Osasco 7
Santa Maria A Vico 7
Tashkent 7
Thái Bình 7
Totale 16.597
Nome #
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 964
Sex Differences in Parkinson’s Disease: From Bench to Bedside 630
Quantitative gait assessment in Parkinsonian patients with or without Mild Cognitive Impairment 585
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 577
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 521
Gender differences in microRNA expression in levodopa-naive PD patients 518
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 493
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 482
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 413
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 411
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach 375
The most effective way to obtain long-term memory is to increase first presentation duration of single words 350
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 308
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 291
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 265
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 264
Dual-task-related gait patterns as possible marker of precocious and subclinical cognitive alterations in Parkinson disease 260
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 246
Classifying Different Stages of Parkinson’s Disease Through Random Forests 240
Metabolomics in Parkinson's disease 229
Diagnostics and Ecological Validity of the Italian Version of the Parkinson's Disease Cognitive Rating Scale 225
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 204
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 200
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 189
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 186
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 179
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 173
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 168
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 165
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 160
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 157
Measurements of Postural Sway to Classify Freezing of Gait in Parkinson's Disease 151
Machine learning can detect the presence of Mild cognitive impairment in patients affected by Parkinson’s Disease 146
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 140
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 138
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 138
A longitudinal study on the effects of COVID-19 pandemic on non-motor symptoms in Parkinson's disease 138
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 131
Increased bilirubin levels in de novo Parkinson's disease 129
A quantitative analysis of muscular co-activation on EMG signals in spastic patients treated with Botulinum toxin 127
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 126
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 125
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 121
Quitting smoking: An early non-motor feature of Parkinson's disease? 120
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 120
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 119
Clinical and neurological abnormalities in adult celiac disease. 115
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 115
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 114
Freezing of gait and executive functions in patients with Parkinson’s disease 112
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 111
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 111
Abnormal eating behaviors in progressive supranuclear palsy. 110
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 110
Bisphenol A glucuronidation in patients with Parkinson's disease 107
Biomechanics Parameters of Gait Analysis to Characterize Parkinson's Disease: A Scoping Review 106
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 106
Machine learning can predict mild cognitive impairment in Parkinson's disease 105
Gender and non motor fluctuations in Parkinson's disease: A prospective study 103
Classifying patients affected by Parkinson’s disease into freezers or non-freezers through machine learning 101
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 100
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 100
Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait 96
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 95
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 94
“Response to Apomorphine in early Parkinson’s disease”. 94
A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study 93
Cognitive correlates of “pure apathy” in Parkinson's disease 92
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 91
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 91
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 91
Gait patterns in Parkinsonian patients with or without mild cognitive impairment. 89
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 89
Music Therapy for Motor and Nonmotor Symptoms of Parkinson's Disease: A Prospective, Randomized, Controlled, Single-Blinded Study 89
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 87
Apathy in Parkinson's disease: differences between caregiver's report and self-evaluation 87
Parkinson’s disease and the spectrum of Lewy body disease 87
Uric acid relates to dopamine transporter availability in Parkinson's disease. 86
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness aspresenting symptoms of PARK-2 86
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 86
Resting-state brain networks in patients with Parkinson's disease and impulse control disorders 86
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 85
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 84
Comment on Szewczyk-Krolikowski et al.: The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort 83
Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system 81
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 81
The Role of Deep Learning and Gait Analysis in Parkinson’s Disease: A Systematic Review 78
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 78
Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? 78
Gait patterns and cognition in Parkinson's disease 78
Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease 77
Resting brain networks in patients with Parkinson's disease and freezing of gait 77
Ropinirole as a treatment of restless legs syndrome in patients on chronichemodialysis: an open randomized crossover trial versus levodopa sustainedrelease 75
Neuropsychological correlates of theory of mind in patients withearly Parkinson's disease. 75
Cognitive contributions to gait and falls: Evidence and implications 75
Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion 75
Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. 74
Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patients. 73
Hemi-restless legs syndrome induced by clebopride 73
Caratteristiche Cliniche 73
Totale 17.305
Categoria #
all - tutte 64.414
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.414


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021602 0 0 0 0 107 60 83 6 68 3 95 180
2021/2022829 9 2 12 14 6 1 7 33 112 117 120 396
2022/20231.274 154 67 37 114 203 295 11 111 185 12 61 24
2023/2024772 44 105 40 42 29 90 25 63 35 57 108 134
2024/20252.220 78 20 31 180 80 182 273 203 320 263 296 294
2025/202611.695 1.587 4.538 3.992 682 896 0 0 0 0 0 0 0
Totale 21.356